These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6608980

  • 21. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 22. Neuromelanin: a role in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Life Sci; 1987 Feb 23; 40(8):705-12. PubMed ID: 2880274
    [Abstract] [Full Text] [Related]

  • 23. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS, Denaro FJ.
    J Neuropathol Exp Neurol; 1988 Jul 23; 47(4):452-8. PubMed ID: 2898510
    [Abstract] [Full Text] [Related]

  • 24. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Heikkila RE, Sieber BA, Manzino L, Sonsalla PK.
    Mol Chem Neuropathol; 1989 Jun 23; 10(3):171-83. PubMed ID: 2669769
    [No Abstract] [Full Text] [Related]

  • 25. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1989 Jun 23; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

  • 26. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.
    Kitt CA, Cork LC, Eidelberg F, Joh TH, Price DL.
    Neuroscience; 1986 Apr 23; 17(4):1089-103. PubMed ID: 2872615
    [Abstract] [Full Text] [Related]

  • 27. The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Marsden CD, Jenner PG.
    Ciba Found Symp; 1987 Apr 23; 126():239-56. PubMed ID: 3556086
    [Abstract] [Full Text] [Related]

  • 28. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
    Cohen G, Pasik P, Cohen B, Leist A, Mytilineou C, Yahr MD.
    Eur J Pharmacol; 1984 Oct 30; 106(1):209-10. PubMed ID: 6442232
    [No Abstract] [Full Text] [Related]

  • 29. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
    Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC.
    Neuroscience; 1991 Oct 30; 41(2-3):507-23. PubMed ID: 1870701
    [Abstract] [Full Text] [Related]

  • 30. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ.
    Proc Natl Acad Sci U S A; 1983 Jul 30; 80(14):4546-50. PubMed ID: 6192438
    [Abstract] [Full Text] [Related]

  • 31. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
    Schwartzman RJ, Alexander GM.
    Brain Res; 1985 Dec 09; 358(1-2):137-43. PubMed ID: 3878182
    [Abstract] [Full Text] [Related]

  • 32. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Neurosci Lett; 1984 Jul 13; 48(1):87-92. PubMed ID: 6332288
    [Abstract] [Full Text] [Related]

  • 33. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
    Pifl C, Schingnitz G, Hornykiewicz O.
    Neurosci Lett; 1988 Oct 05; 92(2):228-33. PubMed ID: 3263594
    [Abstract] [Full Text] [Related]

  • 34. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M, Kettler R, Keller HH, Bonetti EP, Imhof R.
    Adv Neurol; 1987 Oct 05; 45():175-8. PubMed ID: 2881442
    [No Abstract] [Full Text] [Related]

  • 35. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW.
    Adv Neurol; 1993 Oct 05; 60():34-9. PubMed ID: 8420148
    [No Abstract] [Full Text] [Related]

  • 36. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Science; 1984 Sep 28; 225(4669):1480-2. PubMed ID: 6332378
    [Abstract] [Full Text] [Related]

  • 37. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
    Quik M, Police S, He L, Di Monte DA, Langston JW.
    Neuroscience; 2000 Sep 28; 98(2):263-73. PubMed ID: 10854757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH.
    Brain Res; 1996 Nov 25; 741(1-2):185-96. PubMed ID: 9001722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.